To investigate the effect of low-density lipoprotein (LDL) apheresis on ocular microcirculation in patients with hypercholesterolaemia. Methods Six patients with hypercholesterolaemia were included in this study. The diameter of retinal vessels was measured continuously with the retinal vessel analyser before and after LDL apheresis. After baseline assessment a monochromatic luminance flicker was applied to evoke retinal vasodilation. Flicker response was then analysed 50, 70 and 120 s after baseline measurement. In addition, cholesterol, high-density lipoprotein, LDL and triglyceride levels were obtained to find a possible correlation between changes in retinal vessel diameter and lipid metabolism before and after apheresis. 
INTRODUCTION
Low-density lipoprotein (LDL) apheresis has become a valid treatment modality for patients with severe hypercholesterolaemia in whom a maximal dietetic and drug treatment has not led to a sufficient decrease in LDL-cholesterol. 1 Most patients undergoing this therapy suffer from manifest coronary heart disease, another atherosclerotic vascular disease (eg, peripheral arterial disease) or an enhanced risk of retinal vessel occlusion with a consecutive impairment of microand macro-perfusion of end organs. A consequence of the hypercholesterolaemia-induced microvascular responses is enhanced vulnerability of the microcirculation to the effects of ischaemia and other inflammatory conditions. 2 Besides an LDL-lowering effect, a single LDL apheresis treatment has been reported to positively influence and improve myocardial 3e5 and cerebral blood flow. 6 Other studies demonstrated a substantial reduction in haemorheologically relevant peptides and as a consequence, a reduction in whole blood viscosity and erythrocyte aggregation rate, 7 8 contributing to an increase in blood flow by an enhanced release of nitric oxide (NO) from the endothelium. 9 Against this background it seems conceivable that not only are the myocardial and the cerebral perfusion affected by LDL apheresis, but also the retinal microcirculation, as the retinal vessels mirror the morphology and function of systemic diseases. Therefore, the aim of the present study was to investigate whether LDL apheresis has an impact on retinal autoregulation in patients with hypercholesterolaemia using the retinal vessel analyser (RVA, Jena, Germany).
METHODS
Six patients with hypercholesterolaemia were included in this study. All patients were recruited from the Dresden Apheresis Center of the Department of Internal Medicine of the University Hospital Carl Gustav Carus, Dresden, and were undergoing LDL apheresis regularly at this Center.
LDL apheresis
LDL apheresis was performed at the LDL-Apheresis Center Dresden using one of four available methods: these methods are described elsewhere in detail and differ with respect to acute relative reductions in LDL-cholesterol. 1 Briefly, one patient received DALI (Directly absorbs atherogenic lipoproteins; Fresenius Medical Care, St Wendel, Germany) treatment, one patient received LF (Lipidfiltration; Octo Nova, Cologne, Germany) treatment and four patients received immunoabsorption (IA; Miltenyi, Bergisch-Gladbach, Germany). Plasma and serum samples were obtained before and immediately after LDL apheresis for analysis of lipoproteins and triglycerides (high-density lipoprotein (HDL), LDL). Clinical chemistry was measured using standard procedures.
Retinal vessel analysis
Patients were initially referred to the Department of Ophthalmology for retinal vessel imaging using the RVA (at approximately at 08.00 hours, before LDL apheresis). Patients had to pass an ophthalmic examination including slit-lamp biomicroscopy, indirect funduscopy and measurement of intraocular pressure with Goldmann applanation tonometry. Patients with glaucoma, age-related macular degeneration, other ocular diseases and previous intraocular surgery were not allowed to participate in this study. After the first retinal imaging, LDL apheresis was performed in the LDLApheresis Center, and at approximately 14.00 hours a second retinal imaging (after LDL apheresis) was performed. All measurements were undertaken in the right eye after using tropicamid 0.5% (Mydrum; Ankerpharm Chauvin, Berlin, Germany) for pupil dilatation according to the following time schedule: after a short resting period to obtain stable haemodynamic conditions, diameter measurements were performed with the RVA. Retinal vessel diameters were measured continuously for 352 s. Diffuse luminance flickering light was applied consecutively at 50, 70 and 120 s. Before and after each flicker period, 60 s of baseline recordings were scheduled.
Retinal vessel imaging was evaluated with the RVA. The RVA is a commercially available system that comprises a fundus camera (Zeiss FF 450; Imedos, Jena, Germany), a video camera, a high-resolution recorder, a real time monitor, and a personal computer with vessel diameter analysing software. The RVA allows the precise determination retinal vessel diameter with a time resolution of 25 readings/s. Retinal irradiance was approx-
, which is approximately 50 times lower than the maximum level allowed for constant illumination of the retina at the wavelengths mentioned below. The system provides excellent reproducibility and sensitivity. 10 In the present study, a major temporal artery and vein were studied. Measurement of retinal vessel diameter was taken between one and two disc diameters from the margin of the optic disc.
Flickering light stimulation
A custom-built device was used for flicker stimulation, with light flashes at a frequency of 8 Hz. Flicker was generated by focusing a 150 W halogen light source on a rotating sector disc, producing a square wave light pattern with a modulation depth of 100%. Using an optical fibre, flicker stimuli were delivered to the eye through the illumination pathways of the fundus camera by the RVA. The flicker was centred on the macula at an angle of approximately 308.
A wavelength separation technique was used to spectrally separate the flicker light from that used to illuminate the fundus. For flicker stimulation, white light in combination with a 550 nm low pass cut-off filter was used. This ensures that only light with wavelengths below 550 nm was used for flicker stimulation. To separate the flickering light from the light illuminating the fundus, an interference filter with a centre wavelength of 577 nm and a bandwidth of 10 nm (Laser Components, Olchingen, Germany) was placed in front of the light source of the fundus camera. This window was chosen because in this spectral range the contrast between the blood vessels and the surrounding tissue is optimal. A retinal irradiance of approximately 220 mW/cm 2 was used to achieve optimal fundus images. A second interference filter that exactly matched the one in the illumination pathway was placed in front of the video camera. This ensured that the light used for flicker stimulation did not reach the charge-coupled device (CCD) chip of the video camera but was perceived by the subject under study. 
Statistical analysis
Statistical analysis was performed using the software SPSS (version 15.0, Chicago, Illinois).
Changes in retinal vessel diameter were expressed as the absolute changes in diameter and per cent changes over baseline values. Baseline values were calculated as an average of the last 30 s before start of the flicker stimulation. Flicker response for the 50 s flicker period was calculated as an average of the last 10 s of stimulation period, for the 70 s of the stimulation period as an average of the last 20 s of the stimulation period, and for the 120 s stimulation as an average of the last 30 s of the visual stimulation. Due to the small number of patients the non-parametric Wilcoxon test for paired samples was performed. A p value <0.05 was considered as the level of significance. Due to multiple testing the p value was adjusted according to Bonferroni to p¼0.05/3. Data are presented as mean6SD.
RESULTS
Six patients were included in this study (four women, two men). The mean age of all patients was 60.3 (range 46e71) years.
The mean diameter of the arterioles before apheresis was showing a trend to statistical significance at all time points (figure 2). Figure 3 shows the overall flicker-induced vasodilatation changes in per cent for the arterioles and the venules before and after apheresis, revealing statistical significance for both the arterioles (p¼0.028) and the venules (p¼0.028). Table 1 indicates the lipid levels and blood pressure before and after apheresis. Cholesterol, HDL, LDL and the triglyceride levels decreased significantly (p¼0.028) after apheresis treatment. Systemic blood pressure (systolic and diastolic) did not Figure 1 Change in diameter of the arterioles (mm) before low-density lipoprotein (LDL) apheresis at baseline (bbaseline) after 50 s (b50), after 70 s (b70) and after 120 s, and after LDL apheresis at baseline (abaseline), after 50 s (a50), after 70 s (a70) and after 120 s (a120)
show any significant change after apheresis p¼0.197 (p¼0.414). Pulse per minute increased significantly (p¼0.038).
Correlation analysis of changes in lipid levels, blood pressure and diameter of the retinal vessels did not show any significant associations (p values not shown).
DISCUSSION
The results of the present study clearly demonstrated an improvement in flicker-induced vasodilatation after a single LDL apheresis treatment in the retinal arterioles and in the venules that was statistically significant in the overall vasodilatation response. Our observation showed that a single LDL apheresis led to an increase in retinal blood flow, which was readily detected by the flicker response of the RVA. To date, previous studies investigating the microcirculation in other organs showed an improvement in coronary flow reserve and thus myocardial perfusion in patients with coronary heart disease and hypercholesterolaemia, and in heart transplant recipients, 15e17 after a single apheresis treatment, presumably by improving the NO-and acetylcholine (ACH)-mediated endothelial vasodilatation. 5 In retinal vessels the vasodilatory response to diffuse luminance flicker stimulation seems also to be mediated by endothelial NO, 18 indicating that the local production of NO in the retinal vessels increases after apheresis, leading to an improvement in vasodilatation and retinal endothelial function in these patients. Our finding is supported by observations of Tamai and colleagues, who described an increase in the endothelium-dependent vasodilatory response in forearm blood flow associated with increased local production of NO metabolites. 19 According to the law of HagenePoiseuille, the microcirculation is directly proportional to the product of vascular radius to the power of four and blood pressure divided by the product of viscosity and vessel length. 20 As vessel length is fairly constant, the three other parameters could theoretically be influenced by LDL apheresis. Other studies have shown a substantial reduction in haemorheologically relevant peptides such as fibrinogen (by up to 60%), plasma viscosity (by <20%) and erythrocyte/thrombocyte aggregation (by >60%), and significant improvements in micro-perfusion in the brain and the skeletal muscle. 21 22 The vessel radius is affected by several different factors, some of which are influenced by LDL apheresis. Kojima et al demonstrated an increase in NO levels in two patients using heparin as an anticoagulant and treated with dextran sulphate adsorption. 9 Another major mechanism proposed as being involved in endothelial dysfunction in patients with hypercholesterolaemia is the presence of a large number of circulating inflammatory oxidative stress markers, such as inflammatory cytokines, cellular adhesion molecules, acute-phase reactants and C-reactive protein, which are significantly reduced by LDL apheresis. 23 24 Interestingly, in a recent study by Ramunni et al in 23 patients with non-arteritic ischaemic optic neuropathy, three weekly sessions of LDL apheresis resulted in a reduction of circulating markers of endothelial dysfunction and this reduction was correlated to a significant improvement in visual fields.
25
In our study both arterioles and venules reacted to flicker light with vasodilatation that was slightly stronger in the venules than in the arterioles. Here, it needs to be noted that the prevalence of hypertension was high among our patients, but all patients showed only mild hypertensive funduscopic retinal changes similar to a fundus hypertonicus grade 1, indicating well controlled blood pressure. It remains unclear whether these changes in retinal arterial vessels would also have been observed in patients with uncontrolled hypertensive blood pressure with more prolonged funduscopic hypertensive changes. Moreover, looking at the baseline values of the arteries and venules before and after apheresis, showing nearly equal diameters, indicates that the effect of LDL apheresis might only be of short duration Figure 2 Change in diameter of the venules (mm) before low-density lipoprotein (LDL) apheresis at baseline (bbaseline), after 50 s (b50), after 70 s (b70) and after 120 s, and after LDL apheresis at baseline (abaseline), after 50 s (a50), after 70 s (a70) and after 120 s (a120) Figure 3 Flicker-induced vasodilatation changes (%) in arterioles and venules before and after LDL apheresis but can be provoked by flicker light. To the best of our knowledge, there are insufficient data dealing with the duration of apheresis therapy on blood perfusion in the cerebrum, skeletal muscle and eye. Unfortunately, we did not perform retinal vessel analysis on these patients to detect possible long-lasting vascular changes in a longer follow-up period after initial apheresis treatment.
One major limitation of this study is certainly the number of patients included in this pilot study. The change in retinal vessel diameter after LDL apheresis showed a trend towards statistical significance. Except for the overall vasodilatation response (figure 3), statistical significance was not obtained, which might be related to the small number of patients in this pilot study. By increasing the sample size in future studies it is conceivable that the level of the p value might improve even more and we would obtain results that were more significant. As a consequence, we were also not able to perform multiple testing to reveal possible associations between LDL parameters and vessel diameter. Our study was, however, not designed for this outcome analysis; a larger sample size may be required to investigate these issues.
Second, for ethical reasons, we could not justify performing LDL apheresis in healthy control subjects. Therefore, we cannot say whether apheresis also produces haemodynamic effects in the absence of hypercholesterolaemia. However, plasma exchange (another procedure that acutely removes LDL), performed for reasons other than hypercholesterolaemia, was associated with unmodified cerebral blood flow, as evaluated by the radioactive xenon technique. 26 Third, employing the RVA, only information about vessel diameter and the reactivity of retinal vessels to flicker stimulation was available. However, given that our measurements were done in one single artery and vein and not in all visible vessels, our data do not represent total cross-sectional retinal vessel diameters. In extrapolation, for determination of changes in blood flow per se, information about blood velocity would be required. In principle, this information could be gained using laser Doppler flowmetry.
The fourth limitation of our study is that all our patients received LDL apheresis for several years so that our study results may not represent the effects of an early single apheresis or depict longitudinal changes. However, a previous study by Mellwig and co-workers comparing initial and chronic LDL apheresis therapy in patients with coronary artery disease revealed similar improvements of coronary perfusion after a single apheresis in the two treatment groups. 5 In this pilot study an improvement in flicker-induced vasodilatation of retinal arterioles and venules was detected for the first time in patients with hypercholesterolaemia after a single LDL apheresis. Our results indicate that ocular blood perfusion is substantially affected by the systemic effect of LDL apheresis in patients suffering from hypercholesterolaemia.
